controls Search Results


86
Macklin Inc dmso control
Dmso Control, supplied by Macklin Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dmso control/product/Macklin Inc
Average 86 stars, based on 1 article reviews
dmso control - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
10X Genomics chromium controller
Chromium Controller, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chromium controller/product/10X Genomics
Average 86 stars, based on 1 article reviews
chromium controller - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

95
Rockland Immunochemicals g l bovine serum albumin bsa
G L Bovine Serum Albumin Bsa, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g l bovine serum albumin bsa/product/Rockland Immunochemicals
Average 95 stars, based on 1 article reviews
g l bovine serum albumin bsa - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

93
Rockland Immunochemicals c57bl 6 mouse serum
C57bl 6 Mouse Serum, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c57bl 6 mouse serum/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
c57bl 6 mouse serum - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
R&D Systems human sp selectin cd62p immunoassay
Human Sp Selectin Cd62p Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human sp selectin cd62p immunoassay/product/R&D Systems
Average 90 stars, based on 1 article reviews
human sp selectin cd62p immunoassay - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

93
Rockland Immunochemicals rabbit polyclonal anti gapdh antibody
Rabbit Polyclonal Anti Gapdh Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti gapdh antibody/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
rabbit polyclonal anti gapdh antibody - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
Rockland Immunochemicals alkaline phosphatase conjugated goat antimouse igg
Figure 3. IVIG does not directly bind 7E3. 7E3 (f) (or control IgG, ) and IVIG were combined in vitro, at a constant IVIG concentration (25 mg/mL) and varying 7E3 concentrations (0-0.1 mg/mL). The positive control was a mouse antihuman IgG. Samples were then added to a microplate coated with antihuman IgG. Murine IgG binding was visualized using a secondary <t>antimouse</t> IgG–alkaline phosphatase conjugate. p-Nitrophenyl phosphate was added, and the plates were read at 405 nm (kinetic assay, over 10 minutes). Assay response to 7E3 did not differ from control (P .164), whereas the positive control differed significantly from control (P .001).
Alkaline Phosphatase Conjugated Goat Antimouse Igg, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alkaline phosphatase conjugated goat antimouse igg/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
alkaline phosphatase conjugated goat antimouse igg - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
R&D Systems human ccl2
Figure 2: Tumor expression of chemokine decoy receptors (CDR) and host genotype of CDR jointly affect breast cancer relapse. A. Effect of tumor phenotype of CDR on relapse-free survival (RFS). P for log rank = 7.5 × 10−6. The RFS curve was derived from the Kaplan-Meier estimate, and the survival differences between groups were compared by log-rank test. B. Effect of host genotype of CDR on RFS. P for log rank = 0.002 C. Joint effect of tumor phenotype and host genotype of CDR on RFS. P-values of the differences between high expression/minor genotype group and high expression/major genotype group, high expression/major genotype group and low expression/ minor genotype group, and low expression/minor genotype group and low expression/major genotype group are 0.007, 0.354, and 0.047, respectively. High expression indicates co-expression of DARC and D6, otherwise low expression. Minor genotype indicates patients with at- least-one protective minor allele, otherwise major genotype. D. Chemokine levels in the supernatant of cells detected by ELISA after 24-hour incubation. For transient transfection, 1 μg pDARC-42G or -42A, 1 μg pD6-373S or -373Y, or the combination of 1 μg variant-type DARC- 42A and 1 μg variant-type pD6-373Y were transfected. An empty expression vector was also used as a control. 72 hours after transfection, the levels of human <t>CCL2</t> and CCL5 in cell supernatants were determined with a sandwich ELISA. Columns represent the mean of three independent experiments; bars, standard error; *, P < 0.05. E. ROC curves assessing the discriminatory performance of the CDR phenotype/ genotype model and the CDR phenotype model for the prediction of disease relapse. P = 0.02 for AUC comparison.
Human Ccl2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ccl2/product/R&D Systems
Average 93 stars, based on 1 article reviews
human ccl2 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
Rockland Immunochemicals β actin rabbit antibody as control
Figure 2: Tumor expression of chemokine decoy receptors (CDR) and host genotype of CDR jointly affect breast cancer relapse. A. Effect of tumor phenotype of CDR on relapse-free survival (RFS). P for log rank = 7.5 × 10−6. The RFS curve was derived from the Kaplan-Meier estimate, and the survival differences between groups were compared by log-rank test. B. Effect of host genotype of CDR on RFS. P for log rank = 0.002 C. Joint effect of tumor phenotype and host genotype of CDR on RFS. P-values of the differences between high expression/minor genotype group and high expression/major genotype group, high expression/major genotype group and low expression/ minor genotype group, and low expression/minor genotype group and low expression/major genotype group are 0.007, 0.354, and 0.047, respectively. High expression indicates co-expression of DARC and D6, otherwise low expression. Minor genotype indicates patients with at- least-one protective minor allele, otherwise major genotype. D. Chemokine levels in the supernatant of cells detected by ELISA after 24-hour incubation. For transient transfection, 1 μg pDARC-42G or -42A, 1 μg pD6-373S or -373Y, or the combination of 1 μg variant-type DARC- 42A and 1 μg variant-type pD6-373Y were transfected. An empty expression vector was also used as a control. 72 hours after transfection, the levels of human <t>CCL2</t> and CCL5 in cell supernatants were determined with a sandwich ELISA. Columns represent the mean of three independent experiments; bars, standard error; *, P < 0.05. E. ROC curves assessing the discriminatory performance of the CDR phenotype/ genotype model and the CDR phenotype model for the prediction of disease relapse. P = 0.02 for AUC comparison.
β Actin Rabbit Antibody As Control, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/β actin rabbit antibody as control/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
β actin rabbit antibody as control - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
R&D Systems sandwich enzyme immunoassay methods
Figure 2: Tumor expression of chemokine decoy receptors (CDR) and host genotype of CDR jointly affect breast cancer relapse. A. Effect of tumor phenotype of CDR on relapse-free survival (RFS). P for log rank = 7.5 × 10−6. The RFS curve was derived from the Kaplan-Meier estimate, and the survival differences between groups were compared by log-rank test. B. Effect of host genotype of CDR on RFS. P for log rank = 0.002 C. Joint effect of tumor phenotype and host genotype of CDR on RFS. P-values of the differences between high expression/minor genotype group and high expression/major genotype group, high expression/major genotype group and low expression/ minor genotype group, and low expression/minor genotype group and low expression/major genotype group are 0.007, 0.354, and 0.047, respectively. High expression indicates co-expression of DARC and D6, otherwise low expression. Minor genotype indicates patients with at- least-one protective minor allele, otherwise major genotype. D. Chemokine levels in the supernatant of cells detected by ELISA after 24-hour incubation. For transient transfection, 1 μg pDARC-42G or -42A, 1 μg pD6-373S or -373Y, or the combination of 1 μg variant-type DARC- 42A and 1 μg variant-type pD6-373Y were transfected. An empty expression vector was also used as a control. 72 hours after transfection, the levels of human <t>CCL2</t> and CCL5 in cell supernatants were determined with a sandwich ELISA. Columns represent the mean of three independent experiments; bars, standard error; *, P < 0.05. E. ROC curves assessing the discriminatory performance of the CDR phenotype/ genotype model and the CDR phenotype model for the prediction of disease relapse. P = 0.02 for AUC comparison.
Sandwich Enzyme Immunoassay Methods, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sandwich enzyme immunoassay methods/product/R&D Systems
Average 93 stars, based on 1 article reviews
sandwich enzyme immunoassay methods - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
R&D Systems human vegf c
Figure 2: Tumor expression of chemokine decoy receptors (CDR) and host genotype of CDR jointly affect breast cancer relapse. A. Effect of tumor phenotype of CDR on relapse-free survival (RFS). P for log rank = 7.5 × 10−6. The RFS curve was derived from the Kaplan-Meier estimate, and the survival differences between groups were compared by log-rank test. B. Effect of host genotype of CDR on RFS. P for log rank = 0.002 C. Joint effect of tumor phenotype and host genotype of CDR on RFS. P-values of the differences between high expression/minor genotype group and high expression/major genotype group, high expression/major genotype group and low expression/ minor genotype group, and low expression/minor genotype group and low expression/major genotype group are 0.007, 0.354, and 0.047, respectively. High expression indicates co-expression of DARC and D6, otherwise low expression. Minor genotype indicates patients with at- least-one protective minor allele, otherwise major genotype. D. Chemokine levels in the supernatant of cells detected by ELISA after 24-hour incubation. For transient transfection, 1 μg pDARC-42G or -42A, 1 μg pD6-373S or -373Y, or the combination of 1 μg variant-type DARC- 42A and 1 μg variant-type pD6-373Y were transfected. An empty expression vector was also used as a control. 72 hours after transfection, the levels of human <t>CCL2</t> and CCL5 in cell supernatants were determined with a sandwich ELISA. Columns represent the mean of three independent experiments; bars, standard error; *, P < 0.05. E. ROC curves assessing the discriminatory performance of the CDR phenotype/ genotype model and the CDR phenotype model for the prediction of disease relapse. P = 0.02 for AUC comparison.
Human Vegf C, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human vegf c/product/R&D Systems
Average 93 stars, based on 1 article reviews
human vegf c - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
R&D Systems quantikine human vegf d immunoassay
Figure 2: Tumor expression of chemokine decoy receptors (CDR) and host genotype of CDR jointly affect breast cancer relapse. A. Effect of tumor phenotype of CDR on relapse-free survival (RFS). P for log rank = 7.5 × 10−6. The RFS curve was derived from the Kaplan-Meier estimate, and the survival differences between groups were compared by log-rank test. B. Effect of host genotype of CDR on RFS. P for log rank = 0.002 C. Joint effect of tumor phenotype and host genotype of CDR on RFS. P-values of the differences between high expression/minor genotype group and high expression/major genotype group, high expression/major genotype group and low expression/ minor genotype group, and low expression/minor genotype group and low expression/major genotype group are 0.007, 0.354, and 0.047, respectively. High expression indicates co-expression of DARC and D6, otherwise low expression. Minor genotype indicates patients with at- least-one protective minor allele, otherwise major genotype. D. Chemokine levels in the supernatant of cells detected by ELISA after 24-hour incubation. For transient transfection, 1 μg pDARC-42G or -42A, 1 μg pD6-373S or -373Y, or the combination of 1 μg variant-type DARC- 42A and 1 μg variant-type pD6-373Y were transfected. An empty expression vector was also used as a control. 72 hours after transfection, the levels of human <t>CCL2</t> and CCL5 in cell supernatants were determined with a sandwich ELISA. Columns represent the mean of three independent experiments; bars, standard error; *, P < 0.05. E. ROC curves assessing the discriminatory performance of the CDR phenotype/ genotype model and the CDR phenotype model for the prediction of disease relapse. P = 0.02 for AUC comparison.
Quantikine Human Vegf D Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantikine human vegf d immunoassay/product/R&D Systems
Average 93 stars, based on 1 article reviews
quantikine human vegf d immunoassay - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

Image Search Results


Figure 3. IVIG does not directly bind 7E3. 7E3 (f) (or control IgG, ) and IVIG were combined in vitro, at a constant IVIG concentration (25 mg/mL) and varying 7E3 concentrations (0-0.1 mg/mL). The positive control was a mouse antihuman IgG. Samples were then added to a microplate coated with antihuman IgG. Murine IgG binding was visualized using a secondary antimouse IgG–alkaline phosphatase conjugate. p-Nitrophenyl phosphate was added, and the plates were read at 405 nm (kinetic assay, over 10 minutes). Assay response to 7E3 did not differ from control (P .164), whereas the positive control differed significantly from control (P .001).

Journal: Blood

Article Title: Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia

doi: 10.1182/blood.v100.6.2087

Figure Lengend Snippet: Figure 3. IVIG does not directly bind 7E3. 7E3 (f) (or control IgG, ) and IVIG were combined in vitro, at a constant IVIG concentration (25 mg/mL) and varying 7E3 concentrations (0-0.1 mg/mL). The positive control was a mouse antihuman IgG. Samples were then added to a microplate coated with antihuman IgG. Murine IgG binding was visualized using a secondary antimouse IgG–alkaline phosphatase conjugate. p-Nitrophenyl phosphate was added, and the plates were read at 405 nm (kinetic assay, over 10 minutes). Assay response to 7E3 did not differ from control (P .164), whereas the positive control differed significantly from control (P .001).

Article Snippet: Goat antihuman IgG (no cross-reactivity to goat and mouse serum proteins) and alkaline phosphatase–conjugated goat antimouse IgG (no cross-reactivity to goat and human serum proteins) were both obtained from Rockland (Gilbertsville, PA).

Techniques: Control, In Vitro, Concentration Assay, Positive Control, Binding Assay, Kinetic Assay

Figure 2: Tumor expression of chemokine decoy receptors (CDR) and host genotype of CDR jointly affect breast cancer relapse. A. Effect of tumor phenotype of CDR on relapse-free survival (RFS). P for log rank = 7.5 × 10−6. The RFS curve was derived from the Kaplan-Meier estimate, and the survival differences between groups were compared by log-rank test. B. Effect of host genotype of CDR on RFS. P for log rank = 0.002 C. Joint effect of tumor phenotype and host genotype of CDR on RFS. P-values of the differences between high expression/minor genotype group and high expression/major genotype group, high expression/major genotype group and low expression/ minor genotype group, and low expression/minor genotype group and low expression/major genotype group are 0.007, 0.354, and 0.047, respectively. High expression indicates co-expression of DARC and D6, otherwise low expression. Minor genotype indicates patients with at- least-one protective minor allele, otherwise major genotype. D. Chemokine levels in the supernatant of cells detected by ELISA after 24-hour incubation. For transient transfection, 1 μg pDARC-42G or -42A, 1 μg pD6-373S or -373Y, or the combination of 1 μg variant-type DARC- 42A and 1 μg variant-type pD6-373Y were transfected. An empty expression vector was also used as a control. 72 hours after transfection, the levels of human CCL2 and CCL5 in cell supernatants were determined with a sandwich ELISA. Columns represent the mean of three independent experiments; bars, standard error; *, P < 0.05. E. ROC curves assessing the discriminatory performance of the CDR phenotype/ genotype model and the CDR phenotype model for the prediction of disease relapse. P = 0.02 for AUC comparison.

Journal: Oncotarget

Article Title: Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.

doi: 10.18632/oncotarget.4470

Figure Lengend Snippet: Figure 2: Tumor expression of chemokine decoy receptors (CDR) and host genotype of CDR jointly affect breast cancer relapse. A. Effect of tumor phenotype of CDR on relapse-free survival (RFS). P for log rank = 7.5 × 10−6. The RFS curve was derived from the Kaplan-Meier estimate, and the survival differences between groups were compared by log-rank test. B. Effect of host genotype of CDR on RFS. P for log rank = 0.002 C. Joint effect of tumor phenotype and host genotype of CDR on RFS. P-values of the differences between high expression/minor genotype group and high expression/major genotype group, high expression/major genotype group and low expression/ minor genotype group, and low expression/minor genotype group and low expression/major genotype group are 0.007, 0.354, and 0.047, respectively. High expression indicates co-expression of DARC and D6, otherwise low expression. Minor genotype indicates patients with at- least-one protective minor allele, otherwise major genotype. D. Chemokine levels in the supernatant of cells detected by ELISA after 24-hour incubation. For transient transfection, 1 μg pDARC-42G or -42A, 1 μg pD6-373S or -373Y, or the combination of 1 μg variant-type DARC- 42A and 1 μg variant-type pD6-373Y were transfected. An empty expression vector was also used as a control. 72 hours after transfection, the levels of human CCL2 and CCL5 in cell supernatants were determined with a sandwich ELISA. Columns represent the mean of three independent experiments; bars, standard error; *, P < 0.05. E. ROC curves assessing the discriminatory performance of the CDR phenotype/ genotype model and the CDR phenotype model for the prediction of disease relapse. P = 0.02 for AUC comparison.

Article Snippet: After 72 hours of transfection, the levels of human CCL2 and CCL5 in cell supernatants were determined with a sandwich ELISA (R&D systems, USA).

Techniques: Expressing, Derivative Assay, Enzyme-linked Immunosorbent Assay, Incubation, Transfection, Variant Assay, Plasmid Preparation, Control, Sandwich ELISA, Comparison